GHK Cu levels decline significantly with age
Figure 1 HCs were HIV, HCV, and HB seronegative, and mainly recruited pre-COVID-19 pandemic
Patients with active cancer, a history of pituitary tumors, or severe metabolic disease should discuss growth-hormone peptide therapy carefully with both their primary clinician and specialist before starting
Purity, concentration, and sterility cannot be assumed without third-party testing
KPV can be administered orally for its gut anti-inflammatory effects
Atherogenic and visceral-obesity indices have been conceded as surrogate cardiovascular diseases (CVD) indicators surpassing the conventional markers due to stronger predictive power for obesity-induced cardiometabolic risk and CVD mortality rate